Oak Street Health Reports Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St set to snap three-day streak of losses despite Middle East clashes
- Oil rises, as US-Iran strikes risk limiting already impaired supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
Oak Street Health (OSH) PT Lowered to $70 at Cantor Fitzgerald
August 10, 2021 3:49 PM EDTCantor Fitzgerald analyst Steven Halper lowered the price target on Oak Street Health (NYSE: OSH) to $70.00 (from $75.00) while maintaining an Overweight rating.
The analyst commented, "We reiterate our Overweight rating on OSH shares, but lower our price target to $70 from $75. After the market close... More
Oak Street Health (OSH) Misses Q2 EPS by 10c
August 9, 2021 4:28 PM EDTOak Street Health (NYSE: OSH) reported Q2 EPS of ($0.44), $0.10 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $353.1 million versus the consensus estimate of $318 million.
GUIDANCE:
Oak Street Health sees FY2021 revenue of $1.37-1.4 billion, versus the... More
